The Neurostimulation Devices Market is benefiting from expanding applications across pain management and neurological care. Spinal cord stimulators, deep brain stimulators, vagus nerve stimulators, and transcranial stimulation technologies are being developed to address diverse therapeutic requirements. Pain management remains the largest application segment, valued at approximately USD 3.49 billion in 2025.

The growing adoption of deep brain stimulation for Parkinson's disease and other movement disorders is further supporting demand. Depression-related neurostimulation is also emerging as a high-growth application, with the report projecting a 14.7% CAGR for depression applications. Hospitals remain the leading end-user group, accounting for around 58% market share, while clinics are expanding as outpatient neurostimulation procedures become more accessible.